Evidence map›Paper›PMID 42249197›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Clinical advances and practice updates in genitourinary cancers: a 2025 review from the multidisciplinary Spanish 'Cambados annual meeting'.

Sergio Vázquez-Estévez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Carlos Álvarez-Fernández, Urbano Anido-Herranz, Cristina Azpitarte Raposeiras, Javier Casas-Nebra, Ovidio Fernández Calvo, Natalia Fernández Núñez and 11 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sergio Vázquez-EstévezMedical Oncology Department, Translational Oncology Research Group HULA (GIOT HULA), Hospital Universitario Lucus Augusti (HULA), Rúa Dr. Ulises Romero, 1, 27003, Lugo, Spain. Sergio.Vazquez.Estevez@sergas.es.ORCID http://orcid.org/0000-0002-4973-3198
Martín Lázaro-QuintelaMedical Oncology Department, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain.
Daniel Pérez-FentesUrology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain.
Emilio Esteban-GonzálezMedical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Carlos Álvarez-FernándezMedical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Urbano Anido-HerranzMedical Oncology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain.
Cristina Azpitarte RaposeirasMedical Oncology Department, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain.
Javier Casas-NebraUrology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
Ovidio Fernández CalvoMedical Oncology Department, Complexo Hospitalario Universitario Ourense, Ourense, Spain.
Natalia Fernández NúñezMedical Oncology Department, Translational Oncology Research Group HULA (GIOT HULA), Hospital Universitario Lucus Augusti (HULA), Rúa Dr. Ulises Romero, 1, 27003, Lugo, Spain.
Alicia Folgar-TorresRadiation Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
Enrique GallardoDepartment of Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.
Carme García LorenzoMedical Oncology Department, Complexo Hospitalario Universitario Ferrol, A Coruña, Spain.
Aránzazu González-Del-AlbaMedical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
David LorenteMedical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain.
María José Méndez-VidalMedical Oncology Department, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
Aurea Molina DíazMedical Oncology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Ignacio Rodríguez GómezUrology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Cristina SuárezMedical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Begoña P ValderramaMedical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Ignacio PeláezMedical Oncology Service, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The annual 'Cambados Consensus Forum on Genitourinary Tumors', held in Pontevedra, Spain, was convened again in October 2025, maintaining its central objective of reviewing and discussing recent therapeutic advances in genitourinary cancers. This multidisciplinary, 2-day meeting, organized by the Santiago de Compostela Health Research Institute (IDIS), brought together leading Spanish experts in medical oncology, radiation oncology, and urology to examine the latest developments in prostate cancer, renal cell carcinoma, and bladder cancer as presented at international congresses and in peer-reviewed publications throughout late 2024 and 2025. This review summarizes the most significant therapeutic updates discussed during the 2025 edition, emphasizing the most practice-changing innovations.

Indexed as

Bladder cancerKidney neoplasms (MeSH)Practice changingProstate cancerProstatic neoplasms (MeSH)Renal cancerRenal cell carcinomaUrinary bladder neoplasms (MeSH)

Identifiers

PMID42249197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.